Los Angeles, CA, United States of America

Michael P Muchin

This inventor holds 2 USPTO granted patents. Top assignee: Acutek International. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 104(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael P Muchin: Innovator in Transdermal Delivery Systems

Introduction

Michael P Muchin is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of transdermal delivery systems, holding two patents that showcase his innovative approach to delivering agents through the skin.

Latest Patents

His latest patents include a "Carrier patch for the delivery of agents to the skin." This invention involves a carrier patch designed to deliver agents locally or systemically via the skin. The patch features a pad with a lower surface area to which an adhesive is adhered. A primary agent is applied to discrete regions of the patch in a manner that minimizes the deleterious effects of the adhesive on the primary agent. The invention also includes methods for the discrete application of the agent to the patch and for using the patch to deliver the agent to the skin.

Career Highlights

Michael P Muchin is associated with Acutek International, where he continues to develop innovative solutions in the field of transdermal delivery. His work has the potential to enhance the effectiveness of drug delivery systems, making treatments more efficient and user-friendly.

Collaborations

Michael collaborates with Jerome D Muchin, contributing to the advancement of their shared goals in innovation and technology.

Conclusion

Michael P Muchin's contributions to the field of transdermal delivery systems highlight his role as a significant inventor. His innovative patents and ongoing work at Acutek International demonstrate his commitment to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…